CHF
24
2
3
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
8.3%
2 terminated out of 24 trials
83.3%
-3.2% vs benchmark
4%
1 trials in Phase 3/4
40%
4 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (24)
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF)
Aiding COPD and CHF Ultrasound-guided Management Through ENhanced Point Of Care UltraSound
AquaPass Device in Treatment of CHF Patients
Biomarkers for Human Heart Failure
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF
A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD
Evaluation of the Multidimensional Dyspnea Profile (MDP)
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Arts & Health Education to Improve Health, Resilience, and Well-Being
Effects of Remote Monitoring of Patients With Heart Failure Based on Smartphone Application
Validation of a Sensor for Non-Invasive Measurements
Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System
FAST PV and mGFR™ Technology in Congestive Heart Failure
Using Videos to Facilitate Advance Care Planning for Patients With Heart Failure
Heart Failure Worsens Muscle Strength in COPD
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
Remotely Monitoring Patients With Chronic Conditions in Their Home
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
Incentive Spirometry in Non-critically Ill Hospitalized Patients With Acute Respiratory Failure